{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T04:06:28Z","timestamp":1772337988927,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,28]]},"DOI":"10.7759\/cureus.104458","type":"journal-article","created":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T03:33:07Z","timestamp":1772335987000},"source":"Crossref","is-referenced-by-count":0,"title":["Breakthrough Varicella During Chemotherapy in Two Vaccinated Children With Acute Leukemia"],"prefix":"10.7759","author":[{"given":"Hayao","family":"Kosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chigusa","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Taketani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Clinical overview of varicella (chickenpox). (2024). Accessed. July 15, 2024: https:\/\/www.cdc.gov\/chickenpox\/hcp\/clinical-overview\/."},{"key":"ref2","unstructured":"Breakthrough varicella fact sheet. (2024). Accessed. April 24, 2024: https:\/\/www.cdc.gov\/chickenpox\/hcp\/communication-resources\/breakthrough-varicella-infographic.html."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa064040","article-title":"Loss of vaccine-induced immunity to varicella over time","volume":"356","author":"Chaves SS","year":"2007","unstructured":"Chaves SS, Gargiullo P, Zhang JX, Civen R, Guris D, Mascola L, Seward JF. Loss of vaccine-induced immunity to varicella over time. N Engl J Med. 2007, 356:1121-9. 10.1056\/NEJMoa064040","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1294069","article-title":"Severe varicella in persons vaccinated with varicella vaccine (breakthrough varicella): a systematic literature review","volume":"16","author":"Leung J","year":"2017","unstructured":"Leung J, Broder KR, Marin M. Severe varicella in persons vaccinated with varicella vaccine (breakthrough varicella): a systematic literature review. Expert Rev Vaccines. 2017, 16:391-400. 10.1080\/14760584.2017.1294069","journal-title":"Expert Rev Vaccines"},{"key":"ref5","article-title":"Notes from the field: varicella-associated death of a vaccinated child with leukemia - California, 2012","volume":"63","author":"Kriner P","year":"2014","unstructured":"Kriner P, Lopez K, Leung J, Harpaz R, Bialek SR. Notes from the field: varicella-associated death of a vaccinated child with leukemia - California, 2012. MMWR Morb Mortal Wkly Rep. 2014, 63:161.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children","volume":"373","author":"Hunger SP","year":"2015","unstructured":"Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015, 373:1541-52. 10.1056\/NEJMra1400972","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-4-620","article-title":"Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group","volume":"103","author":"Bennett JM","year":"1985","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med. 1985, 103:620-5. 10.7326\/0003-4819-103-4-620","journal-title":"Ann Intern Med"},{"key":"ref8","unstructured":"Clinical features of chickenpox (varicella). (2024). Accessed. June 5, 2024: https:\/\/www.cdc.gov\/chickenpox\/hcp\/clinical-signs\/index.html."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1086\/590358","article-title":"An outbreak of varicella with likely breakthrough disease in a population of pediatric cancer patients","volume":"29","author":"Adler AL","year":"2008","unstructured":"Adler AL, Casper C, Boeckh M, Heath J, Zerr DM. An outbreak of varicella with likely breakthrough disease in a population of pediatric cancer patients. Infect Control Hosp Epidemiol. 2008, 29:866-70. 10.1086\/590358","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/v15020439","article-title":"Herpes simplex virus and varicella zoster virus infections in cancer patients","volume":"15","author":"Tayyar R","year":"2023","unstructured":"Tayyar R, Ho D. Herpes simplex virus and varicella zoster virus infections in cancer patients. Viruses. 2023, 15:439. 10.3390\/v15020439","journal-title":"Viruses"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(82)80725-7","article-title":"Acyclovir therapy of chickenpox in immunosuppressed children\u2014a collaborative study","volume":"101","author":"Prober CG","year":"1982","unstructured":"Prober CG, Kirk LE, Keeney RE. Acyclovir therapy of chickenpox in immunosuppressed children\u2014a collaborative study. J Pediatr. 1982, 101:622-625. 10.1016\/s0022-3476(82)80725-7","journal-title":"J Pediatr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/157.2.309","article-title":"Acyclovir prevents dissemination of varicella in immunocompromised children","volume":"157","author":"Nyerges G","year":"1988","unstructured":"Nyerges G, Meszner Z, Gyarmati E, Kerpel-Fronius S. Acyclovir prevents dissemination of varicella in immunocompromised children. J Infect Dis. 1988, 157:309-13. 10.1093\/infdis\/157.2.309","journal-title":"J Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2013.06.043","article-title":"Breakthrough varicella in a cancer patient with persistent varicella antibody after one varicella vaccination","volume":"163","author":"Yamada M","year":"2013","unstructured":"Yamada M, Kamberos N, Grose C. Breakthrough varicella in a cancer patient with persistent varicella antibody after one varicella vaccination. J Pediatr. 2013, 163:1511-3. 10.1016\/j.jpeds.2013.06.043","journal-title":"J Pediatr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piw078","article-title":"Varicella in a previously immune patient with leukemia","volume":"6","author":"Sewnarine M","year":"2017","unstructured":"Sewnarine M, Rajan S, Redner A, Rubin LG. Varicella in a previously immune patient with leukemia. J Pediatric Infect Dis Soc. 2017, 6:e4-6. 10.1093\/jpids\/piw078","journal-title":"J Pediatric Infect Dis Soc"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70172","article-title":"A study on the persistence of immunity following two-dose varicella vaccination with varying intervals in Chinese children aged 2-7 years","volume":"97","author":"Sun X","year":"2025","unstructured":"Sun X, Zhang L, Wang Z, Wang W. A study on the persistence of immunity following two-dose varicella vaccination with varying intervals in Chinese children aged 2-7 years. J Med Virol. 2025, 97:e70172. 10.1002\/jmv.70172","journal-title":"J Med Virol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1663121","article-title":"Varicella vaccine dose depended effectiveness and waning among preschool children in Hong Kong","volume":"16","author":"Chan YD","year":"2020","unstructured":"Chan YD, Edmunds WJ, Chan HL, et al.. Varicella vaccine dose depended effectiveness and waning among preschool children in Hong Kong. Hum Vaccin Immunother. 2020, 16:499-505. 10.1080\/21645515.2019.1663121","journal-title":"Hum Vaccin Immunother"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09776-1","article-title":"Disseminated vaccine-strain varicella-zoster virus reactivation in an adolescent with secondary immunodeficiency: a case report and literature review","volume":"24","author":"Fashina OA","year":"2024","unstructured":"Fashina OA, Chuang TM, Galardy PJ, Huskins WC, Levy ER, Streck NT, Chakraborty R. Disseminated vaccine-strain varicella-zoster virus reactivation in an adolescent with secondary immunodeficiency: a case report and literature review. BMC Infect Dis. 2024, 24:1296. 10.1186\/s12879-024-09776-1","journal-title":"BMC Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1055\/s-0044-1786997","article-title":"Late-onset concurrent infection of vaccine strain VZV and HSV-1 after varicella vaccination in a child with natural killer T cell deficiency","volume":"19","author":"Kutlu NO","year":"2024","unstructured":"Kutlu NO, Karabey M, Alacam S, et al.. Late-onset concurrent infection of vaccine strain VZV and HSV-1 after varicella vaccination in a child with natural killer T cell deficiency. J Pediatr Infect Dis. 2024, 19:247-250. 10.1055\/s-0044-1786997","journal-title":"J Pediatr Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/469242-breakthrough-varicella-during-chemotherapy-in-two-vaccinated-children-with-acute-leukemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T03:33:09Z","timestamp":1772335989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/469242-breakthrough-varicella-during-chemotherapy-in-two-vaccinated-children-with-acute-leukemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.104458","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,28]]}}}